BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 19731191)

  • 1. [Erectile dysfunction after radical prostatectomy].
    Becker AJ; Stief CG; Stadler TC
    Aktuelle Urol; 2009 Sep; 40(5):289-93. PubMed ID: 19731191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficacy and satisfaction profile, between penile prosthesis implantation and oral PDE5 inhibitor tadalafil therapy, in men with nerve-sparing radical prostatectomy erectile dysfunction.
    Megas G; Papadopoulos G; Stathouros G; Moschonas D; Gkialas I; Ntoumas K
    BJU Int; 2013 Jul; 112(2):E169-76. PubMed ID: 23253640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current management of erectile dysfunction after cancer treatment.
    Peltier A; van Velthoven R; Roumeguère T
    Curr Opin Oncol; 2009 Jul; 21(4):303-9. PubMed ID: 19509501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy.
    Salonia A; Gallina A; Zanni G; Briganti A; Dehò F; Saccà A; Suardi N; Barbieri L; Guazzoni G; Rigatti P; Montorsi F
    Eur Urol; 2008 Mar; 53(3):564-70. PubMed ID: 17761385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing and managing erectile dysfunction after prostatectomy for prostate cancer.
    Albaugh JA
    Urol Nurs; 2010; 30(3):167-177, 166. PubMed ID: 20648854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
    Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
    Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on erectile dysfunction in prostate cancer patients.
    Kendirci M; Bejma J; Hellstrom WJ
    Curr Opin Urol; 2006 May; 16(3):186-95. PubMed ID: 16679857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolving role of testosterone in the treatment of erectile dysfunction.
    Shabsigh R; Rajfer J; Aversa A; Traish AM; Yassin A; Kalinchenko SY; Buvat J
    Int J Clin Pract; 2006 Sep; 60(9):1087-92. PubMed ID: 16939550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erectile function after radical prostatectomy.
    Mulcahy JJ
    Semin Urol Oncol; 2000 Feb; 18(1):71-5. PubMed ID: 10719936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penile rehabilitation following radical prostatectomy.
    Mulhall JP
    Curr Opin Urol; 2008 Nov; 18(6):613-20. PubMed ID: 18832948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for phosphodiesterase 5 inhibitor use post-radical prostatectomy: experimental and clinical review.
    Rambhatla A; Kovanecz I; Ferrini M; Gonzalez-Cadavid NF; Rajfer J
    Int J Impot Res; 2008; 20(1):30-4. PubMed ID: 17673932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Erectile dysfunction and obstructive sleep apnea syndrome].
    Zhuravlev VN; Frank MA; Gomzhin AI
    Urologiia; 2008; (2):35, 37-9. PubMed ID: 18572768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erectile dysfunction after radical prostatectomy: pathophysiology, evaluation and treatment].
    Audouin M; Beley S; Cour F; Vaessen C; Chartier-Kastler E; Bitker MO; Richard F; Rouprêt M
    Prog Urol; 2010 Mar; 20(3):172-82. PubMed ID: 20230937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Have phosphodiesterase-5 inhibitors changed the indications for penile implants?
    Cortés-González JR; Glina S
    BJU Int; 2009 Jun; 103(11):1518-21. PubMed ID: 19220270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase type 5 inhibitor therapy: identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction.
    Axilrod AC
    Curr Med Res Opin; 2007 Dec; 23(12):3189-98. PubMed ID: 17991309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting preservation of erectile function in men undergoing open radical retropubic prostatectomy.
    Marien T; Sankin A; Lepor H
    J Urol; 2009 Apr; 181(4):1817-22. PubMed ID: 19233413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Erectile dysfunction and renal chronic insufficiency: etiology and management].
    Phé V; Roupret M; Ferhi K; Barrou B; Cussenot O; Traxer O; Haab F; Beley S
    Prog Urol; 2009 Jan; 19(1):1-7. PubMed ID: 19135635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rehabilitation of erectile function following radical prostatectomy.
    McCullough AR
    Asian J Androl; 2008 Jan; 10(1):61-74. PubMed ID: 18087645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erectile dysfunction post-radical prostatectomy - a challenge for both patient and physician.
    Bratu O; Oprea I; Marcu D; Spinu D; Niculae A; Geavlete B; Mischianu D
    J Med Life; 2017; 10(1):13-18. PubMed ID: 28255370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of testosterone replacement therapy following radical prostatectomy.
    Khera M; Lipshultz LI
    Urol Clin North Am; 2007 Nov; 34(4):549-53, vi. PubMed ID: 17983894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.